Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): A systematic review

BMJ Open

Volumn 4, Issue 2, 2014, Pages

  Brurberg, Kjetil Gundro ^a   Fønhus, Marita Sporstøl ^a   Larun, Lillebeth ^a   Flottorp, Signe ^a,b   Malterud, Kirsti ^c,d,e  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d Uni Research   (Norway)

^e Research Unit for General Practice in Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC FATIGUE SYNDROME; EMBASE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; POPULATION MODEL; PROGNOSIS; REPRODUCIBILITY; REVIEW; SYSTEMATIC REVIEW; VALIDATION STUDY; CLASSIFICATION; SEVERITY OF ILLNESS INDEX;

FATIGUE SYNDROME, CHRONIC; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84896881725     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003973     Document Type: Review

References (92)

1. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003;160:221-36. (Pubitemid 41110447)
2. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006;367:346-55. (Pubitemid 43151468)
3. White PD. What causes chronic fatigue syndrome? BMJ 2004;329:928-9. (Pubitemid 39422902)
4. Komaroff AL, Geiger AM, Wormsely S. IgG subclass deficiencies in chronic fatigue syndrome. Lancet 1988;1:1288-9.
5. Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997;24:372-6. (Pubitemid 27104105)
6. Lorusso L, Mikhaylova SV, Capelli E, et al . Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009;8:287-91.
7. Wensaas KA, Langeland N, Hanevik K, et al. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut 2012;61:214-19.
8. Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods 1988;21:3-10.
9. Fluge O, Bruland O, Risa K, et al. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 2011;6:e26358.
10. Kerr JR, Petty R, Burke B, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 2008;197:1171-84. (Pubitemid 351590053)
11. Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res 1997;31:59-65. (Pubitemid 27230853)
12. Kato K, Sullivan PF, Evengard B, et al. Premorbid predictors of chronic fatigue. Arch Gen Psychiatry 2006;63:1267-72. (Pubitemid 44708085)
13. Knoop H, Prins JB, Moss-Morris R, et al. The central role of cognitive processes in the perpetuation of chronic fatigue syndrome. J Psychosom Res 2010;68:489-94.
14. de Lange FP, Kalkman JS, Bleijenberg G, et al. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005;26:777-81.
15. Okada T, Tanaka M, Kuratsune H, et al. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 2004;4:14.
16. Wyller VB, Godang K, Morkrid L, et al. Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: relation to clinical symptoms. Pediatrics 2007;120:e129-37. (Pubitemid 47036226)
17. Wyller VB, Saul JP, Amlie JP, et al. Sympathetic predominance of cardiovascular regulation during mild orthostatic stress in adolescents with chronic fatigue. Clin Physiol Funct Imaging 2007;27:231-8. (Pubitemid 46939035)
18. Parker AJ, Wessely S, Cleare AJ. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med 2001;31:1331-45. (Pubitemid 33040358)
19. Van HB, Van Den Eede F, Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? Med Hypotheses 2009;72:701-5.
20. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-9.
21. Maes M, Twisk FNM, Johnson C. Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res 2012;200:754-60.
22. Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11:7-115. (Pubitemid 36258836)
23. Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med 2011;270:327-38.
24. Johnston S, Brenu EW, Staines DR, et al. The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. Ann Epidemiol 2013;23:371-6.
25. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-4. (Pubitemid 36110721)
26. Reitsma JB, Rutjes AW, Khan KS, et al. A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol 2009;62:797-806.
27. Johnston S, Brenu EW, Staines D, et al. The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol 2013;5:105-10.
28. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
29. Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 2012;65:934-9.
30. Dillman DA, Eltinge JL, Groves RM, et al. Survey nonresponse in design, data collection and analysis. In Groves RM, Kalton G, Rao JNK, Schwartz N, Skinner C. eds Survey nonresponse. New York: John Wiley & Sons, Inc., 2002:3-26.
31. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013. http://www.R-project.org/ (accessed 29 Aug 2013).
32. Lumley T. rmeta: meta-analysis. R package version 2.16. 2012. http://CRAN.R-project.org/package=rmeta (accessed 6 Aug 2013).
33. Jason LA, Brown A, Clyne E, et al. Contrasting case definitions for chronic fatigue syndrome, myalgic encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Eval Health Prof 2012;35:280-304.
34. Osoba T, Pheby D, Gray S, et al. The development of an epidemiological definition for myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr 2008;14:16-84.
35. Jones JF, Kohl KS, Ahmadipour N, et al . Fatigue: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007;25:5685-96. (Pubitemid 47043208)
36. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003;3: 31-9.
37. Dowsett EG, Ramsay AM, McCartney RA, et al. Myalgic encephalomyelitis: a persistent enteroviral infection? Postgrad Med J 1990;66:1990-530.
38. Komaroff AL, Fagioli LR, Geiger AM, et al . An examination of the working case definition of chronic fatigue syndrome. Am J Med 1996;100:56-64. (Pubitemid 26049327)
39. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9. (Pubitemid 24370860)
40. Sharpe MC, Archard LC, Banatvala JE, et al . A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
41. Jason LA, Corradi K, Torres-Harding S. Toward an empirical case definition of CFS. J Soc Serv Res 2007;34:43-54.
42. Ramsey MA. Myalgic encephalomyelitis and postviral fatigue states: the saga of royal free disease. 2nd edn. London, UK: Gower, 1988.
43. Ho-Yen DO. Patient management of post-viral fatigue syndrome. Br J Gen Pract 1990;40:37-9.
44. Lloyd AR, Hickie I, Boughton CR, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990;153:522-8. (Pubitemid 20387414)
45. Hyde BM. The nightingale definition of myalgic encephalomyelitis (M.E.). Ottawa, Canada: The Nightingale Research Foundation, 2007.
46. National Collaborating Center for Primary Care. NICE clinical guideline 53. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children. London: National Institute for Health and Clinical Excellence, 2007.
47. Jason LA, Evans M, Porter N, et al. The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am J Biochem Biotechnol 2010;6:120-35.
48. The National Task Force on Chronic Fatigue Syndrome. Report from the National Task Force on chronic fatigue syndrome (CFS), post viral fatigue syndrome (PVFS), myalgic encephalomyelitis (ME). Bristol: Westcare, The National Task Force on Chronic Fatigue Syndrome, 1994.
49. Hartz AJ, Kuhn EM, Levine PH. Characteristics of fatigued persons associated with features of chronic fatigue syndrome. J Chronic Fatigue Syndr 1998;4:71-97. (Pubitemid 28374518)
50. Nacul LC, Lacerda EM, Pheby D, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med 2011;9:91.
51. Pheby D, Lacerda E, Nacul L, et al. A disease register for ME/CFS: report of a pilot study. BMC Res Notes 2011;4:139.
52. Jason LA, Torres-Harding SR, Jurgens A, et al. Comparing the Fukuda et al. criteria and the Canadian case definition for chronic fatigue syndrome. J Chronic Fatigue Syndr 2004;12:2004-52.
53. Brown AA, Jason LA, Evans MA, et al. Contrasting case definitions: the ME International Consensus Criteria vs. the Fukuda et al. CFS criteria. North Am J Psychol 2013;15:103-20.
54. Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449-55. (Pubitemid 27415000)
55. Lindal E, Stefansson JG, Bergmann S. The prevalence of chronic fatigue syndrome in Iceland-a national comparison by gender drawing on four different criteria. Nord J Psychiatry 2002;56:273-7.
56. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993;153:2759-65. (Pubitemid 24005651)
57. Kawakami N, Iwata N, Fujihara S, et al. Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 1998;186:33-41.
58. Lawrie SM, Pelosi AJ. Chronic fatigue syndrome in the community. Prevalence and associations. Br J Psychiatry 1995;166:793-7.
59. Swanink CM, Vercoulen JH, Bleijenberg G, et al. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med 1995;237:499-506.
60. White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011;377:823-36.
61. Hamilton WT, Gallagher AM, Thomas JM, et al. The prognosis of different fatigue diagnostic labels: a longitudinal survey. Fam Pract 2005;22:383-8. (Pubitemid 41487372)
62. Chalder T, Power MJ, Wessely S. Chronic fatigue in the community: 'a question of attribution'. Psychol Med 1996;26:791-800. (Pubitemid 26244116)
63. Reeves WC, Wagner D, Nisenbaum R, et al. Chronic fatigue syndrome: a clinically empirical approach to its definition and study. BMC Med 2005;3:19.
64. Reeves WC, Jones JF, Maloney E, et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Popul Health Metr 2007;5:5.
65. Jason LA, Najar N, Porter N, et al. Evaluating the Centers for Disease Control's empirical chronic fatigue syndrome case definition. J Disabil Policy Stud 2009;20:93-100.
66. Twisk FN, Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol Lett 2009;30:284-99.
67. Mearin F, Lacy BE. Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil 2012;24:791-801.
68. Pawlikowska T, Chalder T, Hirsch SR, et al. Population based study of fatigue and psychological distress. BMJ 1994;308:763-6. (Pubitemid 24087440)
69. Brimacombe M, Helmer D, Natelson BH. Clinical differences exist between patients fulfilling the 1988 and 1994 case definitions of chronic fatigue syndrome. J Clin Psychol Med S 2002;9:309-14. (Pubitemid 35378698)
70. Jason LA, Torres-Harding SR, Taylor RR, et al. A comparison of the 1988 and 1994 diagnostic criteria for chronic fatigue syndrome. J Clin Psychol Med S 2001;8:337-43. (Pubitemid 33076757)
71. Jason LA, Skendrovic B, Furst J, et al. Data mining: comparing the empiric CFS to the Canadian ME/CFS case definition. J Clin Psychol 2012;68:41-9.
72. Jason LA, Helgerson J, Torres-Harding SR, et al. Variability in diagnostic criteria for chronic fatigue syndrome may result in substantial differences in patterns of symptoms and disability. Eval Health Prof 2003;26:3-22.
73. Wearden AJ, Dowrick C, Chew-Graham C, et al. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ 2010;340:c1777.
74. Stubhaug B, Lie SA, Ursin H, et al. Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial. Br J Psychiatry 2008;192:217-23. (Pubitemid 351347381)
75. Bazelmans E, Vercoulen JHMM, Swanink CMA, et al. Chronic fatigue syndrome and primary fibromyalgia syndrome as recognized by GPs. Fam Pract 1999;16:602-4. (Pubitemid 30000176)
76. Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific northwest health care system. Ann Intern Med 1995;123:15-88.
77. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study. Ciba Found Symp 1993;173:83-93.
78. Price RK, North CS, Wessely S, et al. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep 1992;107:514-22.
79. Versluis RG, de Waal MW, Opmeer C, et al. Prevalence of chronic fatigue syndrome in 4 family practices in Leiden. Ned Tijdschr Geneeskd 1997;141:1523-6. (Pubitemid 27317272)
80. Bierl C, Nisenbaum R, Hoaglin DC, et al. Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metrics 2004;2:1.
81. Cho HJ, Menezes PR, Hotopf M, et al . Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition. Br J Psychiatry 2009;194:117-22.
82. Evengård B, Jacks A, Pedersen NL, et al. The epidemiology of chronic fatigue in the Swedish Twin Registry. Psychol Med 2005;35:1317-26.
83. Hamaguchi M, Kawahito Y, Takeda N, et al. Characteristics of chronic fatigue syndrome in a Japanese community population: chronic fatigue syndrome in Japan. Clin Rheumatol 2011;30:895-906.
84. Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-37. (Pubitemid 29483152)
85. Kim CH, Shin HC, Won CW. Prevalence of chronic fatigue and chronic fatigue syndrome in Korea: community-based primary care study. J Korean Med Sci 2005;20:529-34.
86. Njoku MG, Jason LA, Torres-Harding SR. The prevalence of chronic fatigue syndrome in Nigeria. J Health Psychol 2007;12:461-74. (Pubitemid 46550049)
87. Reyes M, Nisenbaum R, Hoaglin DC, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003;163:1530-6. (Pubitemid 36835096)
88. Steele L, Dobbins JG, Fukuda K, et al. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998;105:83S-90S.
89. van't Leven M, Zielhuis GA, van der Meer JW, et al. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health 2010;20:251-7.
90. Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clin Proc 2012;87:1145-52.
91. Yiu YM, Qiu MY. A preliminary epidemiological study and discussion on traditional Chinese medicine pathogenesis of chronic fatigue syndrome in Hong Kong. Zhong Xi Yi Jie He Xue Bao/J Chin Integr Med 2005;3:359-62.
92. Ho-Yen DO, McNamara I. General practitioners' experience of the chronic fatigue syndrome. Br J Gen Pract 1991;41:324-6.